Open access
Open access
Powered by Google Translator Translator

Small Randomized Trial Suggests Metformin May be Effective for Left Ventricular Hypertrophy in Patients with Coronary Artery Disease Without Diabetes

19 Apr, 2019 | 08:37h | UTC

A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial – European Heart Journal (free)

Commentaries: Diabetes drug Metformin may fight heart disease, study says – UPI (free) AND Diabetic drug shown to reduce the risk of heart disease in non-diabetic patients – University of Dundee (free) AND Metformin reduces left ventricular mass in nondiabetic patients with CAD – Cardiovascular Business (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.